NCT01301690

Brief Summary

3,6-bis(1-methyl-4-vinylpyridinium) carbazole diiodide (BMVC) is an inorganic chemical compound (Figure1). The uptake of BMVC in cancer cells and normal cells are different. Recently, a simple handheld device (Figure1) based on the fluorescence analysis of stained cells was established to instantly differentiate cancer cells from normal cells. The investigators want to quantitatively measure the fluorescence expression of BMVC in normal and cancer cells and explore the usefulness of this staining in head and neck lumps.

Trial Health

55
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
100

participants targeted

Target at P50-P75 for all trials

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 1, 2010

Completed
1.1 years until next milestone

First Submitted

Initial submission to the registry

February 21, 2011

Completed
2 days until next milestone

First Posted

Study publicly available on registry

February 23, 2011

Completed
Last Updated

September 19, 2011

Status Verified

September 1, 2011

First QC Date

February 21, 2011

Last Update Submit

September 16, 2011

Conditions

Neck Mass

Keywords

neck massultrasoundFNABMVC

Study Arms (1)

Neck masses

Neck mass received US and US-FNA

Eligibility Criteria

Age18 Years - 90 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

We propose to collect consecutive patients (age range from 18 to 90 years old) with neck lumps, receiving sonographic examination and FNA cytologic study.

You may qualify if:

  • patients (age range from 18 to 90 years old) with neck lumps, receiving sonographic examination and FNA cytologic study.

You may not qualify if:

  • No cytology data

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Department of Otolaryngology Far Eastern Memorial Hospital

Taipei, Taiwan

RECRUITING

Related Publications (1)

  • Liao LJ, Kang CC, Jan IS, Chen HC, Wang CL, Lou PJ, Chang TC. Improved diagnostic accuracy of malignant neck lumps by a simple BMVC staining assay. Analyst. 2009 Apr;134(4):708-11. doi: 10.1039/b814417f. Epub 2009 Jan 24.

    PMID: 19305919BACKGROUND

Study Officials

  • Li-Jen Liao, MD

    Department of Otolaryngology Far Eastern Memorial Hospital, Taipei, Taiwan

    STUDY DIRECTOR

Central Study Contacts

Li-Jen Liao, MD

CONTACT

+886-0-8967-1592deniro@mail2000.com.tw

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Department of Otolaryngology

Study Record Dates

First Submitted

February 21, 2011

First Posted

February 23, 2011

Study Start

January 1, 2010

Last Updated

September 19, 2011

Record last verified: 2011-09

Locations

TW(1)